EURO PHARMA

Grâce-Hollogne ·KBO/BCE: BE 0784.494.230

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
30-06-2025	31-01-2026	30-01-2026	1 d early	2026-00020633
30-06-2024	31-01-2025	18-02-2025	18 d late	2025-00035828
30-06-2023	31-01-2024	05-01-2024	26 d early	2024-00543526

Metric	This company	Sector median	Position in the sector
Solvency	-198.1%	30.5%	better than 5% of 110 sector peers
Net result	€-36k	€11k	better than 5% of 110 sector peers
Equity	€-435k	€28k	better than 5% of 110 sector peers
Gross operating margin	€18k	€36k	better than 29% of 110 sector peers
Staff costs	€35	€49k	higher than 7% of 32 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€220k
Fixed assets	21/28	€182k
Tangible fixed assets	22/27	€182k
Current assets	29/58	€38k
Amounts receivable within one year	40/41	€37k
Cash & bank	54/58	€547
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€220k
Equity	10/15	€-435k
Contributions / capital	10/11	€5k
Accumulated profits (losses)	14	€-440k
Amounts payable	17/49	€655k
Amounts payable after one year	17	€425k
Amounts payable within one year	42/48	€229k
Trade debts payable within one year	44	€143k
Income statement
Gross operating margin	9900	€18k
Operating result	9901	€-26k
Financial income	75	€0
Financial charges	65	€10k
Result before taxes	9903	€-36k
Net result for the period	9904	€-36k
Result to be appropriated	9905	€-36k

Summary